Regression of liver fibrosis is progressive after sustained virological response to HCV therapy in patients with hepatitis C and HIV coinfection. (Q42238105)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 April 2013

Language	Label	Description	Also known as
English	Regression of liver fibrosis is progressive after sustained virological response to HCV therapy in patients with hepatitis C and HIV coinfection.	scientific article published on 25 April 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24304452%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Regression of liver fibrosis is progressive after sustained virological response to HCV therapy in patients with hepatitis C and HIV coinfection (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24304452%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

María Jesús Pérez-Elías

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24304452%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

J L Casado

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24304452%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

C Quereda

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24304452%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

A Moreno

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24304452%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

P Martí-Belda

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24304452%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

S Moreno

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24304452%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

25 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24304452%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24304452%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

20

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24304452%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24304452%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

829-837

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24304452%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Effects of interferon treatment response on liver complications of chronic hepatitis C: 9-year follow-up study

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Interobserver concordance in the assessment of liver fibrosis in HIV/HCV-coinfected patients using transient elastometry.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Non-invasive evaluation of liver fibrosis using transient elastography

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: A 5-year follow-up of 150 patients

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Histological response to pegIFNalpha-2a (40KD) plus ribavirin in HIV-hepatitis C virus co-infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

HIV coinfection does not compromise liver histological response to interferon therapy in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Impact of peginterferon alpha-2b and ribavirin treatment on liver tissue in patients with HCV or HCV-HIV co-infection.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Lower liver stiffness in patients with sustained virological response 4 years after treatment for chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

HIV infection increases HCV-induced hepatocyte apoptosis

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Fibrogenic cell reversion underlies fibrosis regression in liver

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Hepatic stellate cells and the reversal of fibrosis

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Time course of histological changes in patients with a sustained biochemical and virological response to interferon-alpha therapy for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

The effects of old age on hepatic stellate cells

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

The effect of unsuccessful treatment with peginterferon and ribavirin on the liver fibrosis course of HIV/HCV-coinfected patients

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Effect of HCV RNA suppression during peginterferon alfa-2a maintenance therapy on clinical outcomes in the HALT-C trial.

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers

1 reference

https://api.crossref.org/works/10.1111%2FJVH.12108

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42238105&oldid=1713863516"